Prot #RV-CL-PTCL-PI-003974: NU 14H04: Phase II Study of Romidepsin Plus Lenalidomide for Patients with Previously Untreated PTCL

Project: Research project

StatusActive
Effective start/end date5/14/155/14/21

Funding

  • Celgene Corporation (Prot #RV-CL-PTCL-PI-003974)